Back to results
US 2021/0228524 A1Published application
Compositions comprising 15-ohepa and methods of using the same
AssigneeAfimmune Limited
InventorsJonathan Rowe, Kevin Duffy, John Climax
Life of this patent
Estimating the term…
Abstract
The present invention relates to the compositions, formulations and methods of treating fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their sequelae by administration of 15-OHEPA.
Claims18
A method for treating or preventing liver disease in a subject comprising, administering to the subject 15-HEPE in an amount effective to treat or prevent liver disease in the subject.
Dependencies are inferred from the claim text.